title: The unexpected benefits of the national piperacillin/tazobactam shortage on antibiotic stewardship.
authors.affiliation: a Infectious Disease Division , Winthrop-University Hospital , Mineola , NY , USA.|b State University of New York, School of Medicine , Stony Brook , NY , USA.
authors.forename: Burke A
authors.initials: BA
authors.lastname: Cunha
mesh_terms: D000900:Anti-Bacterial Agents / Q000008:administration & dosage*; D016360:Clostridioides difficile / Q000187:drug effects; D011307:Drug Prescriptions / Q000706:statistics & numerical data; D004351:Drug Resistance; D004363:Drug Utilization / Q000706:statistics & numerical data; D004755:Enterobacteriaceae / Q000187:drug effects; D006801:Humans; D007711:Klebsiella pneumoniae / Q000187:drug effects; D010397:Penicillanic Acid / Q000008:administration & dosage / Q000031:analogs & derivatives*; D010878:Piperacillin / Q000008:administration & dosage; D000077725:Piperacillin, Tazobactam Drug Combination; D011550:Pseudomonas aeruginosa / Q000187:drug effects; D012706:Serratia marcescens / Q000187:drug effects; D013211:Staphylococcus aureus / Q000187:drug effects
chemical_list: D000900:Anti-Bacterial Agents; D000077725:Piperacillin, Tazobactam Drug Combination; D010397:Penicillanic Acid; D010878:Piperacillin